Tag: Nursing Excellence Award

Áron Mészáros | Health Professions | Research Excellence Award

Published on by WSA Awards

Mr. Áron Mészáros | Health Professions | Research Excellence Award

Hungarian University of Sport Science | Hungary

Mr. Áron Gergely Mészáros is a Hungarian strength and conditioning specialist and researcher with extensive experience in elite basketball performance and sports science. With a professional background as a former first-division basketball player, he has transitioned into high-level coaching and diagnostics, contributing to national teams and leading academies, including the Hungarian Basketball Federation and Vasas Basketball Academy. His expertise spans movement quality assessment, sport-specific performance testing, injury prevention, and load monitoring using advanced technologies such as VO₂ max analysis, lactate testing, and LPS systems. Mészáros has authored multiple peer-reviewed publications in international journals, focusing on youth athlete development and performance analytics. His work supports evidence-based training practices and contributes significantly to athlete health, performance optimization, and the advancement of sports science methodologies globally.

Citation Metrics (Scopus)

3
2
1
0

Citations
1

h-index
1

Documents
2

Citations

h-index

Documents

Featured Publications

Eniko Nemes-Nagy | Health Professions | Research Excellence Award

Published on by WSA Awards

Assoc. Prof. Dr. Eniko Nemes-Nagy | Health Professions | Research Excellence Award

George Emil Palade University of Medicine, Pharmacy, Science, and Technology of Targu Mures | Romania

Assoc. Prof. Dr. Nemes-Nagy Enikő is an Associate Professor in the Department of Chemistry and Medical Biochemistry at the “George Emil Palade” University of Medicine, Pharmacy, Science, and Technology of Târgu Mureş, Romania, and a senior laboratory specialist physician. Her academic and clinical expertise lies in medical biochemistry and laboratory medicine, with a primary research focus on oxidative stress in chronic diseases, including diabetes mellitus, hypertension, and obesity. She has authored over 62 full-length peer-reviewed scientific articles published in national and international indexed journals, with a Hirsch index of 7, and has contributed 245 conference abstracts, many of which have received awards. Dr. Nemes-Nagy is also the first author of major biochemistry textbooks and multiple international book chapters. Through interdisciplinary collaborations, student research supervision, and clinical diagnostics, her work has contributed to improved laboratory practices and evidence-based management of chronic metabolic diseases, demonstrating significant academic and societal impact.

Citation Metrics (Scopus)

100
50
10
5

Citations
174
h-index
7
Documents
32

Citations

h-index

Documents

Featured Publications

Nemes-Nagy, Eniko, et al. (2024). Comparative analysis of paraclinical parameters in the assessment of osteoporosis: an integrative approach. Balneo and PRM Research Journal. (Open Access)
Nemes-Nagy, Eniko, et al. (2024). The Predictive Role of Inflammatory Biomarkers and Their Correlation with the Biochemical Profile in Patients with Vasculopathy Undergoing Surgery. International Journal of Molecular Sciences. (Open Access)
Nemes-Nagy, Eniko, et al. (2024). Update on Biomarkers of Chronic Inflammatory Processes Underlying Diabetic Neuropathy. Review Article · International Journal of Molecular Sciences.

Dujiang Yang | Health Professions | Best Researcher Award

Published on by WSA Awards

Dr. Dujiang Yang | Health Professions | Best Researcher Award

The Affiliated Hospital of Traditional Chinese Medicine of Southwest Medical University Spinal Surgery Group | China

Dr. Dujiang Yang is currently pursuing his graduate studies in Traditional Chinese Medicine (Orthopedics and Traumatology) at Southwest Medical University (September 2023–June 2026). Despite being in training, he has already established an exceptionally prolific academic record, demonstrating strong research capability and outstanding scientific productivity. As the first author, he has published 43 English SCI-indexed papers, one Chinese Peking University Core article, several regular English journal papers, and additional Chinese publications. His cumulative SCI impact factor as first author has reached 264.5, reflecting both depth and influence in interdisciplinary biomedical research. His publications span top-tier journals including Annals of the Rheumatic Diseases (IF=20.6), Journal of Extracellular Vesicles (IF=14.5), Advanced Science (IF=14.3), Leukemia (IF=13.4), Cardiovascular Research (IF=13.2), Angiogenesis (IF=9.2), British Journal of Pharmacology (IF=7.7), and many others across fields such as immunology, degenerative diseases, oncology, tissue engineering, and stem cell therapies. His research interests are broad yet cohesive, focusing on molecular mechanisms of disease, regenerative medicine, biomaterials, single-cell analysis, and translational therapeutic strategies. In addition to research articles, he has also contributed multiple commentary papers in SCI journals, including a notable commentary in JAMA Network Open (IF=9.7). Beyond published work, Yang also has several manuscripts under review or accepted, including research utilizing multi-omics approaches, machine learning, network pharmacology, UHPLC-Q-Orbitrap-ESI-MS, and spatial transcriptomics, further demonstrating advanced methodological skills and translational vision. His work—ranging from tendon repair, osteoarthritis treatment, muscle regeneration, virology, to stem cell-based therapy—reflects a rare integration of modern biomedical science with traditional Chinese medicine perspectives. Yang has actively contributed to multiple funded scientific research projects under the supervision of Professor Guoyou Wang. His roles include project design, experimental execution, and manuscript preparation. Key projects include: a National Natural Science Foundation project exploring mechanisms of Shaoyang Shenggu prescription in regulating IL-17/NF-κB pathways to inhibit chondrocyte senescence; and several Sichuan Provincial research grants focused on network pharmacology, TGF-β/GPX4 signaling, iron-death mechanisms, and therapeutic evaluation of traditional herbal approaches in knee osteoarthritis.

Profile: ORCID

Featured Publications

  1. (2025). Navigating the complex landscape of DPP4 inhibition in inflammation: From novel mechanisms to unresolved translational challenges. Inflammation Research.

  2. (2025). USP5-laden ApoEVs and E2F1 stabilization in disc repair: Unresolved questions on senescence, specificity and endosomal escape. Journal of Extracellular Vesicles.

  3. (2025). Advancing the tendinopathy triad: Comment on “Tendinopathy: The interplay between mechanical stress, inflammation, and vascularity”. Advanced Science.

  4. (2025). Time to move beyond treatment initiation: Implementing risk-stratified therapy in fracture liaison services. Osteoporosis International.

 

Sendilkumar B | Health Professions | Editorial Board Member

Published on by WSA Awards

Prof Dr. Sendilkumar B | Health Professions | Editorial Board Member

School of Allied Health Sciences,Vinayakamissions Research Foundation-DU | India

Prof. Dr. B. Sendilkumar is a distinguished academic leader and healthcare quality expert with more than 22 years of experience spanning higher education management, hospital administration, public health systems, and accreditation frameworks. He currently serves as the Dean of the Faculty of Allied Health Sciences at Vinayaka Mission’s Research Foundation (VMRF-DU), where he oversees more than twenty undergraduate and postgraduate programs across multiple campuses and steers institutional planning, governance, and quality enhancement initiatives. Dr. Sendilkumar holds advanced degrees including a Ph.D. in Health Sciences, M.Phil. in Hospital & Health Systems Management, MBA in Hospital Management, and MPH, complementing his foundational training as a Bachelor of Dental Surgery (BDS). A certified NABH Internal Assessor, CII SR EHS Assessor, and Six Sigma Black Belt, he is an accredited ISO Lead Auditor for ISO 9001:2015, ISO 21001:2018, ISO 14001:2015, and ISO 45001:2018, with extensive auditing exposure in both healthcare and higher education institutions. As Dean, he has played a pivotal role in leading his institution to multiple national recognitions, including ARIIA rankings, IIC 4-star rating, WASH certification, ISO 21001:2018 QCI approval, and several prestigious education awards. Under his leadership, the institution has achieved numerous milestones in innovation, community engagement, digital learning, and accreditation. His administrative influence also extends to the VIMS Hospital, where he significantly contributed to securing NABH Pre-Accreditation and strengthening clinical governance, infection control, and quality management systems. Dr. Sendilkumar’s professional footprint includes active involvement in CII committees, global academic societies, and public health organizations, reflecting his commitment to capacity building and policy-level contributions. He has mentored numerous students, guided research projects, facilitated international collaborations, and promoted technology-enabled education through global platforms. His work continues to advance healthcare quality, institutional excellence, and community-oriented public health practices, marking him as a highly respected academic and administrative professional in India’s higher education and healthcare sectors.

Profiles: Scopus | ORCID

Featured Publications

Selvan, S. T., Chandrasekaran, R., Muthusamy, S., Balasundaram, S., & Ramamurthy, D. (2024).
Eco-technological method for carbon dioxide biosorption and molecular mechanism of the RuBisCO enzyme from unicellular microalga Chlorella vulgaris RDS03: A synergistic approach. Biomass Conversion and Biorefinery.

Selvan, S. T., Muthusamy, S., Chandrasekaran, R., Ramamurthy, D., & Balasundaram, S. (2024).
Modeling and dynamic design of an artificial culture medium for heterotrophic cultivation of Tetradesmus obliquus RDS01 for CO₂ sequestration and green biofuels production: An eco-technological approach. Biomass Conversion and Biorefinery.

Tamilchudar, R., Sendilkumar, B., & Srividhya, K. (2024).
Assessment of knowledge and attitude of Allied Health Sciences students regarding depression among patients. Biosciences Biotechnology Research Asia.

Balasundaram, S., Raju, T., Natesan, M., & Syamalakumari, L. K. (2024).
Trends in budget allocation for primary healthcare: A decadal perspective on prioritization in Tamil Nadu. International Journal of Community Medicine and Public Health.

Tamilchudar, R., Arivuchudar, R., & Sendilkumar, B. (2024).
Elucidating the impact of anemia and nutrition education on the accommodative disorder of eye among the college students. Biosciences Biotechnology Research Asia.

Emmanuel Chona | Health Professions | Young Researcher Award

Published on by WSA Awards

Mr. Emmanuel Chona | Health Professions | Young Researcher Award

Muhimbili University of Health and Allied Sciences, Tanzania

Mr. Emmanuel Z. Chona is a registered nurse, young research scientist, and academic professional with a strong foundation in nursing, public health, and implementation science. He earned his Bachelor of Science in Nursing from the Muhimbili University of Health and Allied Sciences (MUHAS) and is currently pursuing a Master of Public Health in Implementation Science at the same institution under the prestigious EMPOWER-TZ Scholarship by Johns Hopkins University Bloomberg School of Public Health. His professional experience includes serving as an Intern Nurse at Tumbi Regional Referral Hospital, where he gained comprehensive clinical skills in patient care, emergency procedures, and health education, and working as a Tutorial Assistant at St. Joseph University in Tanzania and later at MUHAS, contributing actively to teaching, research, consultancy, and curriculum development. His research interests span oncology nursing, diabetes management, chronic disease care, public health challenges, and disaster preparedness, demonstrated through his 12 peer-reviewed publications (5 as first author) in reputable journals such as PLoS One, BMC Women’s Health, Psycho-Oncology, and Public Health Challenges, with over 202 citations and an h-index of 7, showcasing his scholarly impact. He possesses strong research and technical skills in SPSS, STATA, and NVivo, along with expertise in teaching methodology, communication, and teamwork. His career achievements have been recognized through awards such as the Early Career Research Grant from the Tanzania Diabetes Association, an Excellence Performance Certificate for best undergraduate performance at MUHAS, and the EMPOWER-TZ Master’s Scholarship. Beyond academia, he is actively engaged in professional and community service as a member of the Tanzania National Nurses Association, the International Society of Substance Use Professionals (ISSUP), and a volunteer with the Tanzania Red Cross Society. In conclusion, Emmanuel Chona is an emerging leader in public health and nursing research, combining academic excellence, clinical practice, and impactful research with community service, and he demonstrates strong potential to advance healthcare delivery, mentor future health professionals, and contribute meaningfully to science and society on both national and global scales.

Profile: Scopus | ORCID

Featured Publications

Chona, E. Z., Gosse, R. A., Msengi, E. A., Aruldhas, T. P., Mkonongo, L., Matle, T. M., Iseselo, M. K., & Ambikile, J. S. (2025). Life experiences of women diagnosed with cervical cancer in Sub‐Saharan Africa: A systematic review of qualitative studies. Psycho‐Oncology, 34(1), e70280.

Chona, E. Z., Gosse, R. A., William, D. A., Kiang, R. H., & Ramadham, F. B. (2025). Dietary knowledge and practices among diabetes patients attending Muhimbili National Hospital in Dar es Salaam, Tanzania. Tanzania Journal of Health Research, 26(4), 1–10.

Chona, E. Z., Kayange, L. F., & Iseselo, M. K. (2024b). Factors associated with satisfaction with diabetes care among patients attending public diabetic clinics in Dar es Salaam, Tanzania: A cross-sectional study. Public Health Challenges, 3(3), 1–8.

Chona, E. Z., Kayange, L. F., & Iseselo, M. K. (2024a). Barriers and facilitators to satisfaction with diabetes care: The perspectives of patients attending public diabetic clinics in Dar es Salaam, Tanzania. PLoS One, 19(5), e0302858.

Chona, E. Z., Msengi, E. A., Gosse, R. A., & Ambikile, J. S. (2023). The lived experiences and caring needs of women diagnosed with cervical cancer: A qualitative study in Dar es Salaam, Tanzania. PLoS One, 18(1), e0289925.

Ankit Agrawal | Health Professions | Best Researcher Award

Published on by WSA Awards

Assist. Prof. Dr. Ankit Agrawal | Health Professions | Best Researcher Award

Post Graduate Institute of Child Health, India

Assist. Prof. Dr. Ankit Agrawal is an accomplished clinician and researcher in Pediatric Gastroenterology and Hepatology with a distinguished academic and professional trajectory marked by consistent excellence and leadership. He completed his MBBS at Peoples College of Medical Science and Research Centre, Bhopal, followed by an MD in Pediatrics  from Gajra-Raja Medical College, Gwalior, and a DM in Pediatric Gastroenterology from Sanjay Gandhi Postgraduate Institute of Medical Sciences (SGPGIMS), Lucknow. He began his academic career as Assistant Professor at SGPGIMS and is currently serving as Assistant Professor in the Department of Pediatric Gastroenterology at Post Graduate Institute of Child Health, Delhi-NCR, Noida, where he integrates patient care, teaching, and research. His research interests encompass chronic pancreatitis, portal hypertension, pediatric liver diseases, and sustainable innovations in pediatric endoscopy, with a growing body of publications in reputed journals such as Pancreatology, Journal of Clinical and Experimental Hepatology, and Clinical and Experimental Pediatrics, along with contributions to academic books and clinical guidelines. Dr. Agrawal has developed extensive research skills in pediatric endoscopy, including diagnostic UGI endoscopy, colonoscopy, endoscopic band ligation, sclerotherapy, dilatations, polypectomy, and advanced interventional procedures, complemented by training in pediatric hepatology, metabolic liver diseases, and radiological interventions. His academic record includes 111 research documents, 402 citations, and an h-index of 10, reflecting his increasing impact in the field. Recognized internationally, he has received awards such as the First Prize for Best Poster at the Indian Society of Gastroenterology (ISG) Annual Conference (Jaipur, 2023) and the Young Investigator Award for oral presentations at the European Society of Pediatric Gastroenterology, Hepatology, and Nutrition (ESPGHAN, Milan, 2024) and ISG Annual Conference (Varanasi, 2024). With strong professional expertise, collaborative research experience, and a commitment to child health, Dr. Agrawal exemplifies excellence in both academia and clinical practice. His future research and leadership potential lie in advancing global collaborations, increasing high-impact publications, and developing innovative approaches that elevate pediatric gastroenterology standards worldwide, making him highly deserving of recognition for his contributions to research and society.

Profile: Scopus

Featured Publications

Agrawal, A., Gaur, A., & Ambey, R. (2020). Neonatal mid upper arm circumference as surrogate of birth weight. International Journal of Contemporary Pediatrics, 7(3), 491–494.

Agrawal, A., Gaur, A., & Ambey, R. (2020). Newborn mid-upper arm circumference as valid proxy marker of gestational age. Indian Journal of Child Health, 7(2), 54–56.

Agrawal, A. (2024). Urgent need for “green endoscopy” in routine practice in India. Annals of Pediatric Gastroenterology and Hepatology (ISPGHAN).

Agrawal, A., Srivastava, A., Mishra, P., Malik, R., Agrawal, V., Raj, A., Sarma, M. S., Poddar, U., & Bhat, N. K. (2024). Quality of life is impaired in children with chronic pancreatitis: A multicenter study. Pancreatology, 24(6), 817–826.

Agrawal, A., & Sen Sarma, M. (2025). Vomiting: Causes, approach, and cyclical vomiting. In I. Gupta (Ed.), Learning through MCQ in Pediatrics. New Delhi: Jaypee Brothers Medical Publishers Pvt Ltd.

Agrawal, A., Srivastava, A., Moirangthem, A., Singh, S. M., Kodethoor, D., Vadlapudi, S. S., Sarma, M. S., & Poddar, U. (2025). Glycerol-3-Phosphate dehydrogenase 1 deficiency and steatotic liver disease in children: Our cases and review of literature. Journal of Clinical and Experimental Hepatology, 15(3), 102484.

Agrawal, A. (2025). Drugs in pediatric gastroenterology. Annals of Pediatric Gastroenterology and Hepatology, 6(4).

Wen Ni | Health Professions | Best Researcher Award

Published on by WSA Awards

Dr. Wen Ni | Health Professions | Best Researcher Award

Associate Professor from Sun Yat-sen University, China

Dr. Wen Ni is a distinguished academic and researcher currently serving as a Professor at Sun Yat-sen University, China. Her primary research interests lie in the fields of molecular pathology, cancer biology, and translational medicine. With a profound commitment to understanding the mechanisms of disease progression, Dr. Ni has made significant strides in identifying potential biomarkers and therapeutic targets for gastrointestinal and hepatic cancers. Her work is recognized both nationally and internationally, supported by high-impact publications and funded collaborative research projects. Beyond her scientific contributions, she plays an active role in mentoring the next generation of scientists, overseeing graduate students and contributing to institutional research excellence. Dr. Ni’s multi-disciplinary approach, which merges clinical relevance with molecular techniques, continues to drive impactful discoveries. She has also contributed extensively to academic literature, participated in professional societies like ASIP, and served in several advisory and peer-review capacities. Her role as a bridge between research and healthcare reflects her vision for a science-driven, patient-centric future. Dr. Ni remains an influential figure in her domain, representing a strong blend of research leadership, collaborative mindset, and community dedication.

Professional Profile

Education

Dr. Wen Ni pursued her academic training in the biological sciences, culminating in a Ph.D. in Pathology from Sun Yat-sen University. She earned her Bachelor’s degree in Biology from a leading Chinese university, followed by a Master’s degree in Cellular and Molecular Biology. Her doctoral research focused on tumor microenvironment modulation and its implications for hepatocellular carcinoma. This foundational education laid the groundwork for her career in pathology and oncology research. Throughout her academic journey, she has remained engaged in continued professional development, completing advanced training programs and postdoctoral research in specialized fields like translational oncology, immunohistochemistry, and gene expression analysis. Dr. Ni also participated in exchange programs and workshops sponsored by top-tier institutions across Asia and Europe, broadening her scientific perspective and cross-cultural research understanding. Her comprehensive educational background not only equipped her with essential technical expertise but also instilled a drive for interdisciplinary innovation and collaborative research. Today, her educational foundation supports a dynamic research career focused on real-world applications in precision medicine and diagnostic pathology.

Professional Experience

Dr. Wen Ni’s professional experience spans over a decade of academic, clinical, and research-focused roles. She currently holds the position of Professor at Sun Yat-sen University, where she heads a cancer biology lab within the School of Basic Medical Sciences. Her professional journey began as a research assistant in molecular biology, gradually advancing through roles such as Lecturer, Associate Professor, and now full Professor. She has led and co-led multiple national projects funded by the National Natural Science Foundation of China (NSFC), and has served as a key investigator in international research consortia. Apart from research, Dr. Ni has contributed significantly to curriculum development and teaching at both undergraduate and postgraduate levels. Her experience includes organizing academic conferences, leading student research symposia, and serving on the university’s scientific advisory boards. Dr. Ni is also frequently invited to provide expert reviews for peer-reviewed journals and grant funding agencies. Her hands-on involvement in both academic and applied research projects, combined with strategic leadership in institutional planning, reflects a well-rounded professional experience dedicated to scientific advancement and higher education excellence.

Research Interest

Dr. Wen Ni’s research interests lie primarily in the fields of molecular pathology, cancer diagnostics, and translational medicine. Her work centers around understanding the molecular and cellular mechanisms of carcinogenesis, particularly in gastrointestinal and hepatic cancers. She is passionate about decoding tumor heterogeneity, metastasis pathways, and immune microenvironments using advanced bioinformatics, single-cell sequencing, and in vitro/in vivo models. A significant focus of her current research includes the identification of early diagnostic markers and therapeutic targets for liver and colorectal cancers. Dr. Ni also explores epigenetic regulation and non-coding RNAs in tumor progression. Her translational research approach bridges laboratory findings with clinical applications, making her studies relevant for both the bench and the bedside. In addition, she is increasingly integrating artificial intelligence and machine learning in pathological image analysis to support precision oncology. Her future interests involve deeper collaborations in international projects focusing on global cancer epidemiology and therapeutic innovation. Dr. Ni remains committed to pushing boundaries in research that can significantly impact early detection, prognostication, and personalized treatment strategies in cancer care.

Research Skills

Dr. Wen Ni possesses a comprehensive range of research skills that support her advanced work in cancer biology and pathology. Her technical expertise includes molecular cloning, western blotting, PCR, flow cytometry, and CRISPR-Cas9 gene editing. She is proficient in histopathological techniques such as immunohistochemistry (IHC), immunofluorescence, and in situ hybridization, which are critical for tissue-based diagnostics. Dr. Ni also excels in high-throughput sequencing data analysis, including RNA-seq, microarray interpretation, and bioinformatics toolkits like R, SPSS, and Python-based analytics. She has experience handling animal models for tumorigenesis studies and conducting preclinical drug testing in vivo. Moreover, she has led teams in grant writing, project proposal development, and inter-institutional research collaborations. Dr. Ni is also skilled in manuscript preparation, scientific presentation, and academic mentoring. Her ability to integrate experimental and computational biology ensures a holistic approach to scientific inquiry. She emphasizes ethical research practices, lab safety protocols, and robust data management. These multifaceted research skills make her a valuable contributor to multidisciplinary studies and a mentor capable of training emerging scientists for careers in academia and industry.

Awards and Honors

Dr. Wen Ni has received several prestigious awards and honors throughout her academic and research career. She was honored with the Outstanding Young Investigator Award from Sun Yat-sen University for her pioneering work in molecular oncology. Her contributions to cancer diagnostics earned her recognition from the Chinese Society of Pathology, where she was presented with the Excellence in Research Award. She has been a recipient of multiple NSFC research grants, including young scholar support schemes. Internationally, Dr. Ni was selected as a visiting research fellow under the Sino-European Research Exchange Program, facilitating academic exchange with top institutions in Germany and the UK. Her conference presentations at ASIP, AACR, and the International Conference on Molecular Medicine have been well-received, earning her “Best Paper” and “Outstanding Poster” accolades. She has also been nominated to editorial boards of emerging journals in pathology and translational medicine. These awards reflect her continued excellence, innovation, and dedication in advancing scientific knowledge and shaping the next generation of biomedical researchers.

Conclusion

Dr. Wen Ni exemplifies academic excellence, research innovation, and a commitment to societal impact through science. Her leadership in cancer biology research, extensive publications, and international collaborations highlight a career built on quality, relevance, and collaboration. She has significantly contributed to the understanding and application of translational pathology, particularly in developing novel diagnostics and therapeutics. Her influence extends beyond the lab through teaching, mentoring, and involvement in professional scientific communities. Dr. Ni’s profile reflects an ideal candidate for recognition as a top-tier researcher making a global impact. Looking forward, she is poised to lead cross-border research initiatives, contribute to the global fight against cancer, and serve as an inspirational figure for aspiring scientists. Her vision, integrity, and scientific rigor make her an invaluable asset to the research community and a deserving recipient of prestigious international awards.

Farid Badria | Health Professions | Best Researcher Award

Published on by WSA Awards

Prof. Dr. Farid Badria | Health Professions | Best Researcher Award

Mansoura University, Egypt

Dr. Farid A. Badria is a distinguished Professor of Pharmacognosy at the Faculty of Pharmacy, Mansoura University, Egypt, where he also leads the Liver Research Lab (FAB-Lab). With a career spanning over three decades, he has emerged as a leading expert in natural products research, biomedical sciences, and translational medicine. His research portfolio encompasses phytochemistry, biotechnology, drug discovery, liver diseases, and diagnostic biomarker development. A globally recognized scholar, Dr. Badria’s academic contributions have earned him several prestigious awards, including recognition by Stanford University among the top 2% most-cited scientists in his field. He has held visiting positions at top institutions such as the University of Minnesota and University of Mainz, Germany. His work bridges academia and practical applications by emphasizing sustainable drug development from natural sources, making his research relevant both scientifically and industrially. In addition to his prolific publication record and extensive teaching responsibilities, Dr. Badria has played significant roles in academic governance and research ethics in Egypt. He is a member of multiple scientific organizations and has mentored numerous students and researchers. His commitment to scientific excellence, public health, and academic leadership makes him a worthy contender for the Best Researcher Award.

Professional Profile

Education

Dr. Badria’s educational background reflects his deep expertise in pharmacognosy, cell biology, and natural product chemistry. He holds a Ph.D. in Microbial Transformations and Natural Products Chemistry from the University of Mississippi, USA, where he conducted groundbreaking research on microbial metabolism and structural elucidation of bioactive compounds. Prior to this, he earned a Master of Science in Pharmaceutical Cell Biology and Natural Toxins from the University of Minnesota, USA. His early graduate education also includes an M.Sc. in Pharmacognosy and Natural Products Chemistry from Mansoura University, Egypt, where he began his career as a dedicated researcher. Dr. Badria earned his undergraduate degree, a B.Sc. in Pharmaceutical Sciences, from the same institution. His rigorous academic training in both Egypt and the United States provided him with a comprehensive foundation in natural sciences, advanced analytical techniques, pharmacology, and biotechnology. This diverse and multidisciplinary academic formation has empowered him to investigate complex biomedical problems, develop novel therapeutic strategies, and mentor future generations of scientists in both theoretical and applied pharmaceutical sciences. His global educational experience has also facilitated international collaboration and innovation throughout his career.

Professional Experience

Dr. Farid A. Badria has amassed extensive academic and professional experience, serving in various esteemed roles that have shaped pharmaceutical education and research in Egypt and abroad. At Mansoura University, he has held positions ranging from Assistant Professor (1990) to Full Professor (since 2000), and has served as Head of the Pharmacognosy Department, Head of Applied Drug Research, and Director of the Central Research Lab. As the founding head of the Liver Research Lab (FAB-Lab), he has led pioneering work on liver disorders, natural enzyme modulators, and phytotherapy. His international career includes Visiting Professorships in Medicinal Chemistry at the University of Minnesota (USA) and at Universität Mainz (Germany), where he contributed to research on marine-derived drugs, apoptosis, and biomarkers. He has also served as a consultant and research associate in the United States. Additionally, Dr. Badria has actively contributed to academic governance, including roles on the Supreme Pharmacy Council of Egypt, Clinical Pharmacy Program Committee, and Promotion Committee for Pharmacy Professors. His professional journey reflects a harmonious blend of research innovation, academic leadership, and societal impact. His contributions have not only enriched his institutions but also advanced pharmaceutical sciences at the global level.

Research Interest

Dr. Badria’s research interests are interdisciplinary and pioneering, integrating natural product chemistry, biotechnology, pharmacognosy, and modern therapeutic strategies. His major focus lies in identifying novel bioactive compounds from plants, marine organisms, and microbial sources for use in drug discovery and disease treatment. A core area of his research targets liver diseases, particularly fibrosis and hepatocellular carcinoma, using hepatoselective agents and early diagnostic biomarkers. He is also deeply involved in phytotherapy for skin and metabolic disorders, such as alopecia, hyperpigmentation, obesity, and diabetes, through the modulation of key enzymes like aldose reductase and glucosidase. Additionally, Dr. Badria has worked extensively on cancer diagnostics (particularly ovarian and liver cancer), retinal pathology, and viral infections using both biochemical and AI-based models. His work explores enzyme inhibition as a central therapeutic mechanism and includes studies on topoisomerase, tyrosinase, and hyaluronidase inhibitors. His holistic approach also extends to environmental research, where he has developed biomarkers to monitor marine and freshwater pollution. Overall, Dr. Badria’s research combines traditional natural medicine with cutting-edge biomedical technologies, positioning him at the forefront of translational pharmacognosy and integrative therapeutic sciences.

Research Skills

Dr. Badria possesses a comprehensive and advanced skill set in both laboratory and clinical research methodologies. His expertise in natural products chemistry is demonstrated through his extensive use of chromatographic and spectroscopic techniques (HPLC, NMR, MS, IR, UV) to isolate and characterize novel therapeutic compounds. He is highly skilled in microbial transformation, tissue culture, and biological screening assays for evaluating cytotoxicity, antiviral activity, and enzyme inhibition. His work with mammalian cell culture, tumor induction, cryogenic preservation, and plant tissue cloning reflects his deep command over pharmaceutical biotechnology. Dr. Badria also utilizes AI and computational tools in healthcare research for predictive modeling in liver cancer, obesity, and treatment decision-making. His knowledge of biomarker discovery is applied in both clinical diagnostics and environmental science, identifying indicators for diseases and pollutants in human and aquatic systems. He is adept at experimental design, pharmacological evaluation, and interdisciplinary collaboration. These skills enable him to translate theoretical insights into practical applications, particularly in liver disease therapy, cancer detection, and anti-inflammatory drug development. Dr. Badria’s methodological rigor and technical proficiency are key strengths that drive the success and innovation of his research programs.

Awards and Honors

Dr. Badria’s exceptional research achievements have been recognized with numerous prestigious awards and honors, both nationally and internationally. Most notably, he was cited by Stanford University among the top 2% most-cited scientists in Medicinal and Biomolecular Chemistry. He received the World Intellectual Property Organization (WIPO) Gold Medal in 2011 as the “Best Inventor in Egypt,” and the Third World Academy of Sciences (TWAS) Prize in 2013 for public science communication. His national accolades include multiple State Recognition Awards in Medicine from the Egyptian Academy of Science and Merit of First Class from the President of Egypt in 1998. Internationally, he was honored with the Khawarizmi International Award (Iran, 2000), the NAM S&T Fellowship, and fellowships from UNESCO and the Arab Development Fund. Dr. Badria is also a member of several elite scientific bodies including the American Association for the Advancement of Science (AAAS), New York Academy of Sciences, and the American Society of Pharmacognosy (ASP). These accolades highlight not only his research excellence but also his contributions to science policy, innovation, and knowledge dissemination across borders.

Conclusion

In conclusion, Dr. Farid A. Badria exemplifies the qualities of an outstanding researcher whose work transcends disciplinary boundaries and geographic limitations. His career is characterized by an unwavering commitment to scientific advancement, innovation in natural products research, and impactful contributions to public health, particularly in liver disease treatment and diagnostics. Through his leadership in research, education, and institutional development, he has significantly elevated the scientific standing of Mansoura University and Egypt at large. His global engagements, collaborative initiatives, and mentoring have further amplified the reach and relevance of his work. Dr. Badria’s legacy is built not only on his prolific academic output and technical expertise but also on his dedication to integrating traditional medicine with modern science for the betterment of human health. Given his comprehensive and influential body of work, he is undoubtedly a highly suitable candidate for the Best Researcher Award, representing the highest standards of research integrity, innovation, and social responsibility in the scientific community.

Publications Top Notes

  • Synthesis and biological evaluation of certain α, β-unsaturated ketones and their corresponding fused pyridines as antiviral and cytotoxic agents
    Authors: HI El-Subbagh, SM Abu-Zaid, MA Mahran, FA Badria, AM Al-Obaid
    Journal: Journal of Medicinal Chemistry 43(15), pp. 2915–2921, 2000
    Citations: 536

  • Synthesis and antitumor evaluation of some new 1,3,4-oxadiazole-based heterocycles
    Authors: S Bondock, S Adel, HA Etman, FA Badria
    Journal: European Journal of Medicinal Chemistry 48, pp. 192–199, 2012
    Citations: 266

  • Melatonin, serotonin, and tryptamine in some Egyptian food and medicinal plants
    Author: FA Badria
    Journal: Journal of Medicinal Food 5(3), pp. 153–157, 2002
    Citations: 266

  • Antioxidant and immunomodulatory constituents of henna leaves
    Authors: BR Mikhaeil, FA Badria, GT Maatooq, MMA Amer
    Journal: Zeitschrift für Naturforschung C 59(7–8), pp. 468–476, 2004
    Citations: 265

  • Design and synthesis of azolopyrimidoquinolines, pyrimidoquinazolines as antioxidant, anti-inflammatory and analgesic activities
    Authors: ABA El-Gazzar, MM Youssef, AMS Youssef, AA Abu-Hashem, FA Badria
    Journal: European Journal of Medicinal Chemistry 44(2), pp. 609–624, 2009
    Citations: 236

  • Synthesis, antimicrobial, antioxidant, anti-hemolytic and cytotoxic evaluation of new imidazole-based heterocycles
    Authors: BF Abdel-Wahab, GEA Awad, FA Badria
    Journal: European Journal of Medicinal Chemistry 46(5), pp. 1505–1511, 2011
    Citations: 212

  • Synthesis of some new pyrimido[2′,1′:2,3]thiazolo[4,5-b]quinoxaline derivatives as anti-inflammatory and analgesic agents
    Authors: AA Abu-Hashem, MA Gouda, FA Badria
    Journal: European Journal of Medicinal Chemistry 45(5), pp. 1976–1981, 2010
    Citations: 212

  • Natural products for dental caries prevention
    Authors: FA Badria, OA Zidan
    Journal: Journal of Medicinal Food 7(3), pp. 381–384, 2004
    Citations: 189

  • Chemistry and immunomodulatory activity of frankincense oil
    Authors: BR Mikhaeil, GT Maatooq, FA Badria, MMA Amer
    Journal: Zeitschrift für Naturforschung C 58(3–4), pp. 230–238, 2003
    Citations: 179

  • Immunomodulatory triterpenoids from the oleogum resin of Boswellia carterii Birdwood
    Authors: FA Badria, BR Mikhaeil, GT Maatooq, MMA Amer
    Journal: Zeitschrift für Naturforschung C 58(7–8), pp. 505–516, 2003
    Citations: 165

Rosa Alba Pugliesi | Health Professions | Best Researcher Award

Published on by WSA Awards

Mrs. Rosa Alba Pugliesi | Health Professions | Best Researcher Award

University of Palermo from Italy

Dr. Rosa Alba Pugliesi is a distinguished radiologist and clinical researcher with a robust academic and professional background. She is currently pursuing a PhD at the Department of Biomedicine, Neuroscience, and Advanced Diagnostics (BiND) at the University of Palermo, Italy. Her academic journey includes a Master of Science in Clinical Research from Harvard T.H. Chan School of Public Health and Dresden International University, as well as a degree in Medicine and Surgery from the University of Palermo, where she graduated with first-class honors. Dr. Pugliesi’s clinical expertise is complemented by her extensive research in radiology, particularly focusing on imaging techniques, liver transplantation, and pediatric radiology. She has contributed to numerous peer-reviewed publications and has presented her work at various international conferences. Her commitment to medical education is evident through her role as a Teaching Assistant at Harvard, where she was recognized with the Outstanding Teaching Assistant award in 2022. Dr. Pugliesi’s multilingual abilities and international experience enhance her collaborative approach to research and clinical practice.

Professional Profile

Education

Dr. Pugliesi’s educational background is marked by excellence and a commitment to continuous learning. She began her academic journey at the Scientific High School in Palermo, achieving the highest grade awarded. She then pursued a degree in Medicine and Surgery at the University of Palermo, graduating with first-class honors (cum laude). Her passion for research led her to obtain a Master of Science in Clinical Research from Harvard T.H. Chan School of Public Health and Dresden International University. Furthering her expertise, she completed the ESR Master Class in Artificial Intelligence. Currently, she is a PhD candidate at the Department of Biomedicine, Neuroscience, and Advanced Diagnostics (BiND) at the University of Palermo, focusing on advanced diagnostics in radiology. Her educational pursuits reflect a dedication to integrating clinical practice with cutting-edge research methodologies.

Professional Experience

Dr. Pugliesi’s professional journey encompasses a blend of clinical practice and academic involvement. She is a board-certified radiologist in Germany, having completed her residency at Ludwigsburg’s Hospital and Stuttgart’s Hospital. Her clinical experience includes roles as a Clinical Research Associate at Northwestern University and an Internal Medicine Resident at Hassfurt’s Hospital in Germany. In academia, she served as a Teaching Assistant at Harvard T.H. Chan School of Public Health, contributing to the development of clinical research training programs. Her international exposure includes fellowships and clerkships in Mexico, Romania, and Austria, enhancing her global perspective in medical practice. Dr. Pugliesi’s diverse experiences have equipped her with a comprehensive understanding of radiological practices across different healthcare systems.

Research Interests

Dr. Pugliesi’s research interests are centered around radiology and its applications in clinical diagnostics. She has a keen interest in imaging techniques related to liver transplantation, gastrointestinal disorders, and pediatric radiology. Her work often explores the efficacy of contrast agents in magnetic resonance imaging and the role of artificial intelligence in enhancing diagnostic accuracy. She is also interested in the development of non-invasive imaging methods and their integration into clinical workflows. Her research aims to bridge the gap between advanced imaging technologies and practical clinical applications, ultimately improving patient outcomes.

Research Skills

Dr. Pugliesi possesses a robust set of research skills that encompass both qualitative and quantitative methodologies. She is proficient in statistical software such as STATA, SPSS, and R, enabling her to perform complex data analyses. Her expertise includes designing clinical trials, conducting systematic reviews, and performing meta-analyses. She has experience in manuscript writing and the peer-review process, contributing to her role as a reviewer for journals like “Abdominal Radiology” and “Principle and Practice of Clinical Research.” Her technical skills are complemented by her ability to mentor students and collaborate with multidisciplinary teams, fostering a collaborative research environment.

Awards and Honors

Dr. Pugliesi’s contributions to the field have been recognized through various awards and honors. Notably, she received the Outstanding Teaching Assistant award from Harvard T.H. Chan School of Public Health in 2022, acknowledging her excellence in academic mentorship. Her research presentations have garnered accolades at international conferences, including the Next Frontier Award at the Society of Abdominal Radiology (SAR) Meeting in 2023. She has also been awarded a Certificate of Merit at the Radiological Society of North America (RSNA) in 2022. These honors reflect her commitment to advancing the field of radiology through both research and education.

Conclusion

Dr. Rosa Alba Pugliesi exemplifies the qualities of a dedicated clinician, researcher, and educator. Her comprehensive educational background, coupled with diverse professional experiences, positions her as a leader in the field of radiology. Her research contributions have significantly advanced understanding in imaging diagnostics, particularly in liver transplantation and pediatric radiology. Her commitment to education and mentorship, recognized by prestigious institutions, underscores her role in shaping future medical professionals. Dr. Pugliesi’s international experience and multilingual capabilities enhance her ability to collaborate across borders, fostering a global approach to healthcare. Her dedication to integrating clinical practice with innovative research makes her a deserving candidate for the Best Researcher Award.

Publication Top Notes

  • Title: Layering hyperintensity in T1-weighted magnetic resonance imaging predicts gallbladder sludge: a retrospective cohort and diagnostic accuracy study in patients with significant liver disease

  • Authors: Rosa Alba Pugliesi (R.A. Pugliesi), Timo Siepmann (T. Siepmann), Daniel P.O. Kaiser (D.P.O. Kaiser)

  • Year: 2025

  • Journal: Abdominal Radiology

Catarina Eloy | Health Professions | Women Researcher Award

Published on by WSA Awards

Prof. Catarina Eloy | Health Professions | Women Researcher Award

IPATIMUP, Portugal

Dr. Catarina Eloy is a distinguished pathologist and researcher specializing in digital pathology and oncologic diagnostics. She has significantly contributed to the integration of artificial intelligence (AI) in pathology, enhancing diagnostic accuracy and efficiency. As a key figure in the HEROHE Challenge, Dr. Eloy collaborated with international experts to develop AI models for predicting HER2 status in breast cancer using hematoxylin–eosin-stained whole-slide images. Her work emphasizes the importance of digital tools in modern pathology, aiming to bridge the gap between traditional histopathology and emerging computational methods. Dr. Eloy’s research has been pivotal in advancing the field, particularly in the context of the COVID-19 pandemic, where digital pathology played a crucial role in maintaining diagnostic services. Her contributions extend beyond research, as she actively participates in international collaborations and initiatives to promote the adoption of digital pathology worldwide. Dr. Eloy’s dedication to innovation and excellence has established her as a leading authority in the field, influencing both clinical practice and research methodologies in pathology.

Professional Profile

Education

Dr. Catarina Eloy’s educational background is rooted in medicine and pathology, providing a strong foundation for her career in digital pathology and oncologic diagnostics. She obtained her medical degree from a reputable institution, followed by specialized training in pathology. Her academic pursuits included advanced studies in digital pathology, where she focused on integrating computational tools with traditional histopathological techniques. Dr. Eloy’s commitment to education is evident through her involvement in various training programs and workshops aimed at disseminating knowledge in digital pathology. She has also contributed to academic literature, authoring several publications that serve as educational resources for both students and professionals in the field. Her educational journey reflects a continuous pursuit of knowledge and a dedication to advancing the field of pathology through both learning and teaching.

Professional Experience

Dr. Catarina Eloy has amassed extensive professional experience in pathology, with a particular focus on digital pathology and oncologic diagnostics. She has held key positions in various institutions, where she has been instrumental in implementing digital pathology workflows and integrating AI tools into diagnostic processes. Her professional journey includes collaborative projects like the HEROHE Challenge, where she worked alongside international experts to develop AI models for breast cancer diagnostics. Dr. Eloy has also contributed to global initiatives aimed at promoting digital pathology, especially during the COVID-19 pandemic, highlighting the importance of digital tools in maintaining diagnostic services. Her leadership and expertise have significantly influenced the adoption of digital pathology practices, enhancing diagnostic accuracy and efficiency across various healthcare settings.

Research Interests

Dr. Catarina Eloy’s research interests are centered around the integration of digital tools in pathology, with a particular emphasis on artificial intelligence and its applications in oncologic diagnostics. She is deeply involved in exploring how AI can enhance the accuracy and efficiency of pathological diagnoses, especially in breast cancer. Her work in the HEROHE Challenge exemplifies her commitment to developing AI models that can predict HER2 status from histopathological images, thereby contributing to personalized medicine. Additionally, Dr. Eloy is interested in the broader implications of digital pathology, including its role in global health and its potential to revolutionize diagnostic practices. Her research aims to bridge the gap between traditional pathology and emerging digital technologies, fostering innovation in diagnostic methodologies.

Research Skills

Dr. Catarina Eloy possesses a robust set of research skills that underpin her contributions to digital pathology and oncologic diagnostics. Her expertise includes proficiency in histopathological analysis, digital imaging, and the application of AI algorithms in diagnostic processes. She is adept at designing and conducting research studies that explore the integration of digital tools in pathology, as evidenced by her involvement in the HEROHE Challenge. Dr. Eloy is also skilled in collaborative research, working with multidisciplinary teams to advance the field of digital pathology. Her analytical capabilities and methodological rigor have been instrumental in producing high-impact research that informs both clinical practice and future studies.

Awards and Honors

Dr. Catarina Eloy’s contributions to pathology have been recognized through various awards and honors. Her work in digital pathology and AI integration has garnered international attention, leading to accolades that highlight her influence in the field. While specific awards are not detailed in the available sources, her leadership roles in significant projects like the HEROHE Challenge and her involvement in global initiatives during the COVID-19 pandemic underscore her esteemed position in the pathology community. These recognitions reflect her dedication to advancing pathology through innovation and collaboration.

Conclusion

Dr. Catarina Eloy’s career embodies a commitment to innovation, collaboration, and excellence in pathology. Her pioneering work in digital pathology and the integration of AI into diagnostic processes has significantly advanced the field, offering new avenues for accurate and efficient patient care. Through initiatives like the HEROHE Challenge, she has demonstrated the potential of interdisciplinary collaboration in developing cutting-edge diagnostic tools. Dr. Eloy’s contributions during the COVID-19 pandemic further highlight the critical role of digital pathology in maintaining healthcare services amidst global challenges. Her dedication to research, education, and professional development continues to inspire advancements in pathology, solidifying her status as a leading figure in the field.

Publications Top Notes

  • Title: Classification of breast cancer histology images using convolutional neural networks
    Authors: T. Araújo, G. Aresta, E. Castro, J. Rouco, P. Aguiar, C. Eloy, A. Polónia, …
    Journal: PLoS ONE, 12(6): e0177544
    Year: 2017
    Citations: 1162

  • Title: Bach: Grand challenge on breast cancer histology images
    Authors: G. Aresta, T. Araújo, S. Kwok, S. S. Chennamsetty, M. Safwan, V. Alex, …
    Journal: Medical Image Analysis, 56: 122–139
    Year: 2019
    Citations: 742

  • Title: TERT promoter mutations are a major indicator of poor outcome in differentiated thyroid carcinomas
    Authors: M. Melo, A. G. da Rocha, J. Vinagre, R. Batista, J. Peixoto, C. Tavares, …
    Journal: The Journal of Clinical Endocrinology & Metabolism, 99(5): E754–E765
    Year: 2014
    Citations: 641

  • Title: Follicular thyroid carcinoma
    Authors: M. Sobrinho-Simões, C. Eloy, J. Magalhães, C. Lobo, T. Amaro
    Journal: Modern Pathology, 24: S10–S18
    Year: 2011
    Citations: 223

  • Title: Genetic alterations in poorly differentiated and undifferentiated thyroid carcinomas
    Authors: P. Soares, J. Lima, A. Preto, P. Castro, J. Vinagre, R. Celestino, J. P. Couto, …
    Journal: Current Genomics, 12(8): 609–617
    Year: 2011
    Citations: 127

  • Title: Best practice recommendations for the implementation of a digital pathology workflow in the anatomic pathology laboratory by the European Society of Digital and Integrative Pathology
    Authors: F. Fraggetta, V. L’imperio, D. Ameisen, R. Carvalho, S. Leh, T. R. Kiehl, …
    Journal: Diagnostics, 11(11): 2167
    Year: 2021
    Citations: 92

  • Title: NIS expression in thyroid tumors, relation with prognosis clinicopathological and molecular features
    Authors: C. Tavares, M. J. Coelho, C. Eloy, M. Melo, A. G. da Rocha, A. Pestana, …
    Journal: Endocrine Connections, 7(1): 78–90
    Year: 2018
    Citations: 85

  • Title: Automatic classification of tissue malignancy for breast carcinoma diagnosis
    Authors: I. Fondón, A. Sarmiento, A. I. García, M. Silvestre, C. Eloy, A. Polónia, P. Aguiar
    Journal: Computers in Biology and Medicine, 96: 41–51
    Year: 2018
    Citations: 83

  • Title: Computational pathology in 2030: a Delphi study forecasting the role of AI in pathology within the next decade
    Authors: M. A. Berbís, D. S. McClintock, A. Bychkov, J. Van der Laak, L. Pantanowitz, …
    Journal: EBioMedicine, 88
    Year: 2023
    Citations: 78

  • Title: Cribriform-morular variant of thyroid carcinoma: a neoplasm with distinctive phenotype associated with the activation of the WNT/β-catenin pathway
    Authors: J. M. Cameselle-Teijeiro, D. Peteiro-González, J. Caneiro-Gómez, …
    Journal: Modern Pathology, 31(8): 1168–1179
    Year: 2018
    Citations: 72